FDA and USPTO have initiated collaboration efforts following the issuance of Executive Order No. 14036, Promoting Competition in the American Economy, encouraging coordination among agencies with overlapping jurisdiction over industries. Earlier this year a joint USPTO-FDA Public Listening Session on Collaboration Initiatives was held to obtain public input on the PTO’s proposed initiatives to foster coordination between the agencies, enhance meaningful innovation in medical product development, and support a competitive marketplace to promote product access and affordability to the public. Panelists will discuss concerns and suggestions raised at this forum and opine on the changing landscape of innovation for industry and progress towards interagency coordination.

Get Access

  • +$100 for nonmembers


Linda E. Horner, Acting Senior Lead Administrative Patent Judge, USPTO
Maarika L. Kimbrell, Partner, Morgan, Lewis & Bockius LLP
George O’Brien, Partner, Mayer Brown LLP
Arti Rai, Elvin R. Latty Professor of Law and Faculty Director, The Center for Innovation Policy, Duke Law
Jay Sitlani, Regulatory Counsel, Office of Regulatory Policy, FDA
Moderated by Brian J. Malkin, Associate General Counsel, TEVA Pharmaceuticals USA, Inc

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.


On-demand content can be played back on most devices.


CLE credit is not currently available for pre-recorded sessions.

Related Content